期刊文献+

卵巢恶性肿瘤细胞药敏及逆转耐药的实验和临床研究 被引量:1

THE CLINICAL AND EXPERIMENT STUDY OF THE REVERSING DRUG RESISTANCE AND DRUG SENSITIVITY TEST IN VITRO FOR OVARIAN NEOPLASMAS
全文增补中
导出
摘要 目的:研究黄体酮、他莫西芬、潘生丁、妇复春等药物对卵巢恶性肿瘤细胞耐药的逆转作用,以及观察应用体外敏感药物及其逆转药的临床治疗疗效。方法:用改进的MTT法检测33例卵巢恶性肿瘤细胞对6种常用化疗药物敏感性及其逆转耐药作用。结果:卵巢癌药敏的顺序为Taxol>DDP>ADM>VP16>PYM>CTX;逆转药对化疗药物逆转(增敏)的顺序为黄体酮>他莫西芬>妇复春>潘生丁。使用敏感药物及其逆转药治疗后,一年以上总有效率为78.78%,其中上皮癌为78.57%。结论:选择敏感化疗药物及其逆转药使治疗个体化,可提高卵巢恶性肿瘤的疗效;黄体酮、他莫西芬可直接增强抗癌效应,并逆转化疗药耐药性,能获得更好的疗效。 To investigate the reversional effect of p rogesterone et al on ovarian neoplasmas in vitro and therapeutic effects on pati ents with ovarian cancer treated with sensitive drug and reverse drug Method:Cytotoxic activity of 6 anticancer drug and reverse drug agains t ovarian neoplasms in vitro were observed by MTT method in 33 cases of ovarian cancerResults:(1),The order of sensitive drug against ovari an neoplasmas were Taxol>DDP>ADM>VP16>PYM>CTX; The order of reverse drug for inc reasing sensitive of these anticancer drugs were Progesterone>Tamoxife>Fu Fu Chu n>Persantin (2), The response rate of patients treated with sensitive anticanc er drug and reverse drug is 78.78%, of which epithelial ovarian cancer is 78.57%Conclusion:The response rate will be improved for pa tients with ovarian cancer by using sensitive anticancer drug and reverse drug i n individualized treatment
出处 《广西医学院学报》 2000年第6期964-966,共3页
基金 广西卫生厅科技基金!(9613)
关键词 逆转耐药 卵巢恶性肿瘤 瘤细胞 药敏 他莫西芬 黄体酮 潘生丁 治疗 药物 顺序 multidrug resistance ovarian neoplasma MTT drug sen sitivity
  • 相关文献

参考文献12

二级参考文献26

共引文献46

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部